Climate change has reduced ocean mixing far more than expected
2021-03-24
(Press-News.org) The ocean is dynamic in nature, playing a crucial role as a planetary thermostat that buffer global warming. However, in response to climate change, the ocean has generally become stabler over the past 50 years. Six times stabler, in fact, than previously estimated--as shown by a new study that researchers from the CNRS, Sorbonne University, and IFREMER have conducted within the scope of an international collaboration.* Warming waters, melting glaciers, and disrupted precipitation patterns have created an ocean surface layer cut off from the depths. Just as oil and water separate, so this division of surface and deeper waters limits oceanic mixing, making it harder for the ocean to mitigate climate change. Furthermore, climate change has strengthened winds, which has thickened the ocean surface layer by 5 to 10 m per decade over the last half century. This has hindered vital access to light for most marine organisms within it. Published in Nature (March 24, 2021), these findings underscore the consequences of climate change and anthropogenic phenomena for the ocean, the life it harbours, and its capacity to remain a global thermostat into the future.
Note:
*The two French research units involved are the Laboratoire d'Océanographie et du Climat--Expérimentations et Approches Numériques (CNRS / IRD / MNHN / Sorbonne University) and the Laboratoire d'Océanographie Physique et Spatiale (CNRS / IFREMER / IRD / Université de Bretagne Occidentale).
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-24
Training babies' brains and bodies might delay the onset of Rett syndrome, a devastating neurological disorder that affects about 1 in 10,000 girls worldwide.
In experiments with mice that replicate the genetic disorder, scientists discovered that intense behavioral training before symptoms develop staves off both memory loss and motor control decline. Compared to untrained mice, those trained early in life were up to five times better at performing tasks that tested their coordination or their ability to learn, Howard Hughes Medical Institute Investigator Huda Zoghbi and her colleagues report March 24, 2021, in the journal Nature.
Those data, from animals whose symptoms closely mimic the human disease, offers a clear rationale for genetically screening newborns for Rett syndrome, ...
2021-03-24
New York, NY (March 24, 2021) -- Immunotherapy is not only significantly less effective in liver cancer patients who previously had a liver disease called non-alcoholic steatohepatitis (NASH), but actually appears to fuel tumor growth, according to a Mount Sinai study published in Nature in March. NASH affects as many as 40 million people worldwide and is associated with obesity and diabetes.
The researchers led a large international collaboration to investigate immunotherapy's effect on hepatocellular carcinoma (HCC), a deadly liver cancer, caused by NASH. They conducted a meta-analysis ...
2021-03-24
New scientific findings bring hope that early training during the presymptomatic phase could help individuals with Rett syndrome, a neurodevelopmental disorder, retain specific motor and memory skills and delay the onset of the condition. Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital reported in the journal Nature that, in a mouse model of Rett syndrome, intensive training beginning before symptoms appear dramatically improved the performance of specific motor and memory tasks and substantially delayed the appearance of symptoms.
The researchers propose that newborn genetic testing for Rett syndrome, followed by prompt intensive training in the skills that will be affected, such ...
2021-03-24
Immunotherapy using checkpoint inhibitors is effective in around a quarter of patients with liver cancer. However, to date, physicians have been unable to predict which patients would benefit from this type of treatment and which would not. Researchers from the German Cancer Research Center have now discovered that liver cancer caused by chronic inflammatory fatty liver disease does not respond to this treatment. On the contrary: in an experimental model, this type of immunotherapy actually promoted the development of liver cancer, as now reported in the journal Nature.
Liver cancer is the sixth most common type of cancer in the world, ...
2021-03-24
The heart of any computer, its central processing unit, is built using semiconductor technology, which is capable of putting billions of transistors onto a single chip. Now, researchers from the group of Menno Veldhorst at QuTech, a collaboration between TU Delft and TNO, have shown that this technology can be used to build a two-dimensional array of qubits to function as a quantum processor. Their work, a crucial milestone for scalable quantum technology, was published today in Nature.
Quantum computers have the potential to solve problems that are impossible to address with classical computers. Whereas current ...
2021-03-24
HOUSTON ? Overcoming previous technical challenges with single-cell DNA (scDNA) sequencing, a group led by researchers at The University of Texas MD Anderson Cancer Center has developed a novel method for scDNA sequencing at single-molecule resolution. This technique revealed for the first time that triple-negative breast cancers undergo continued genetic copy number changes after an initial burst of chromosome instability.
The findings, published today in Nature, offer an accurate and efficient new approach for sequencing hundreds of individual cancer cells while also providing novel insights into cancer evolution. These insights may explain why treatments are ...
2021-03-24
Joint press release by the German Cancer Research Center, University Medicine Mannheim, Heidelberg University Hospital, and the National Center for Tumor Diseases (NCT) Heidelberg
Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors. The vaccine proved to be safe and triggered the desired immune response in the tumor tissue, as the team now reports in the journal Nature.
Diffuse ...
2021-03-24
Researchers have developed experimental flu shots that protect animals from a wide variety of seasonal and pandemic influenza strains. The vaccine product is currently being advanced toward clinical testing. If proven safe and effective, these next-generation influenza vaccines may replace current seasonal options by providing protection against many more strains that current vaccines do not adequately cover.
A study detailing how the new flu vaccines were designed and how they protect mice, ferrets, and nonhuman primates appears in the March 24 edition of the journal Nature. This work was led by researchers at the University of Washington School of Medicine and the Vaccine
Research Center part of the National Institute of Allergy ...
2021-03-24
Many children of low-income families across the country do not have access to quality health care. Lack of health care can have a domino effect, affecting educational outcomes in the classroom.
School-based telehealth could offer a sustainable and effective solution, according to a new report in the Journal for Nurse Practitioners by Kathryn King Cristaldi, M.D., the medical director of the school-based telehealth program, and Kelli Garber, the lead advanced practice provider and clinical integration specialist for the program.
The program through the MUSC Health Center for Telehealth has effectively served over 70 schools across the state of South Carolina. Evaluating a child at school via telehealth ...
2021-03-24
Probiotics -- those bacteria that are good for your digestive tract -- are short-lived, rarely taking residence or colonizing the gut. But a new study from researchers at the University of California, Davis, finds that in breast milk-fed babies given the probiotic B. infantis, the probiotic will persist in the baby's gut for up to one year and play a valuable role in a healthy digestive system. The study was published in the journal Pediatric Research.
"The same group had shown in a previous study that giving breast milk-fed babies B. infantis had beneficial effects that lasted up to 30 days after supplementation, but this is the first study to show persistent colonization up to 1 year of age," said lead author Jennifer Smilowitz with the UC Davis Department ...
LAST 30 PRESS RELEASES:
[Press-News.org] Climate change has reduced ocean mixing far more than expected
